5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation.
Zimmerman
R A
RA
Department of Urology, University of Oklahoma Health Sciences Center, 920 Stanton L Young Blvd, Oklahoma City, OK 73104, USA.
Dozmorov
I
I
Nunlist
E H
EH
Tang
Y
Y
Li
X
X
Cowan
R
R
Centola
M
M
Frank
M B
MB
Culkin
D J
DJ
Lin
H-K
HK
D045930:Anabolic Agents / Q000494:pharmacology*; D015113:Androstane-3,17-diol / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D019295:Computational Biology; D004815:Epidermal Growth Factor / Q000494:pharmacology; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D020411:Oligonucleotide Array Sequence Analysis; D011471:Prostatic Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D011944:Receptors, Androgen / Q000235:genetics; D015398:Signal Transduction; D014407:Tumor Cells, Cultured
D045930:Anabolic Agents; D011944:Receptors, Androgen; D015113:Androstane-3,17-diol; D004815:Epidermal Growth Factor